Jun Inoue, Takehiro Akahane, Tomoo Kobayashi, Osamu Kimura, Kosuke Sato, Masashi Ninomiya, Tomoaki Iwata, Satoshi Takai, Norihiro Kisara, Toshihiro Sato, Futoshi Nagasaki, Masahito Miura, Takuya Nakamura, Teruyuki Umetsu, Akitoshi Sano, Mio Tsuruoka, Masazumi Onuki, Satoko Sawahashi, Hirofumi Niitsuma, Atsushi Masamune
AIM: Nucleos(t)ide analogs (NAs) do not completely prevent hepatocellular carcinoma (HCC) in chronic hepatitis B virus (HBV) infection. This study aimed to evaluate the dynamics of a non-invasive liver fibrosis marker, FIB-4 index, for predicting HCC development. METHODS: Among a total of 882 chronically HBV-infected patients who were treated with NAs, 472 patients without HCC history whose FIB-4 at baseline and 1 year of treatment was obtained were evaluated for the incidence of HCC...
August 25, 2023: Hepatology Research: the Official Journal of the Japan Society of Hepatology